Live news related to THX PHARMA stock (FR0013286259): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
THX Pharma, a biopharmaceutical company specializing in rare neurological diseases, has disclosed its cash position as of December 31, 2025. This anno…
THX Pharma has signed a strategic licensing agreement with the pharmaceutical group Biocodex for the development and commercial exploitation of two dr…
Portzamparc établit une recommandation d'achat sur THX PHARMA ce mercredi 11 février 2026.
THX Pharma and Biocodex have announced the signing of a strategic licensing agreement for two drug candidates aimed at treating three rare neurologica…
The biopharmaceutical company THX Pharma announced on Monday its financial communication agenda for the year 2026. The company noted that announcement…
THX Pharma (Theranexus) announced on January 8 the online publication of its shareholder letter, according to a press release issued Wednesday evening…
The Board of Directors of THX Pharma has appointed Julien Veys as Deputy CEO, according to a statement released on January 7. This appointment is part…
